Capstone Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Capstone Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,900	Closed	-$1.05M	–	2106
2021 Q4	$1.05M	Sell	6,900 -1,100	-14%	-$170K	﹤0.01%	1286
2021 Q3	$1.29M	Sell	8,000 -35,000	-81%	-$5.89M	﹤0.01%	1331
2021 Q2	$7.04M	Buy	+43,000	New	+$6.62M	0.02%	636
2019 Q3	–	Sell	-12,800	Closed	-$1.4M	–	1400
2019 Q2	$1.4M	Buy	+12,800	New	+$1.36M	0.01%	841
2015 Q4	–	Sell	-30,000	Closed	-$3.03M	–	505
2015 Q3	$3.03M	Buy	+30,000	New	+$3.6M	0.07%	167
2014 Q3	–	Sell	-101,100	Closed	-$8.66M	–	467
2014 Q2	$8.66M	Sell	101,100 -25,800	-20%	-$2.03M	0.11%	142
2014 Q1	$10M	Buy	+126,900	New	+$10.6M	0.13%	113

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capstone Investment Advisors's IBB Position: Q2 2022 in Review

Capstone Investment Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 3 shares.

Capstone Investment Advisors first reported a position in IBB in Q1 2014 and held it in 9 quarters. The position peaked at $1.09M in Q1 2014. 859 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

Capstone Investment Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
Capstone Investment Advisors sold 3 iShares Biotechnology ETF shares in Q2 2022.
Capstone Investment Advisors first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 9 quarters.
Capstone Investment Advisors's iShares Biotechnology ETF position peaked at $1.09M in Q1 2014.
859 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Capstone Investment Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.